14 results for “bactericidal”

Set a search alert

Research ArticleOpen accessIn the abstractCOMPARATIVE STUDY OF ANTIBACTERIAL ACTIVITY OF PLANT EXTRACTS FROM SEVERAL REGIONS OF ASIAAwatif Al-Judaibi, Ashwag Al-Zahrani, Khadijah A. Altammar et al.This study was designed to investigate the antibacterial activities of alcohol extracts of Phoenix dactylifera (date palm ’type Ajwa’), Nigella sativa (black cumin), Elettaria cardamomum (cardamom), Tinospora crispa (Akar patawali) and Panax ginseng (ginseng). The plant extracts were prepared with methanol and assayed for antibacterial activity against Methicillin-Resistant Staphylococcus Aureus (MRSA) and S. aureus. Extracts of N. sativa, E. cardamomum … …American Journal of Pharmacology and Toxicology, Vol. 9, Issue 2 · 2 Apr 2014 · 7,569 accessesView PDF Cite

Research ArticleOpen accessIn the abstractAntibacterial Activity of Hydroalcoholic Extract of Callistemon citrinus and Albizia lebbeckSeyyed Mansour Seyydnejad, Masumeh Niknejad, Ismaieel Darabpoor, Hossein MotamediProblem statement: Callistemon citrinus and Albizia lebbeck are two kind of native plants in Khoozestan province in Iran, according to the agreement that medicinal plant could be replaced the medicine we are trying to determine the antibacterial effect of the named plants. Approach: The antibacterial properties of ethanolic and methanolic extract of Callistemon citrinus leaf and Albizia lebbeck leaf was … …American Journal of Applied Sciences, Vol. 7, Issue 1 · 31 Jan 2010 · 9,077 accessesView PDF Cite

Research ArticleOpen accessIn the abstractPharmacodynamic Comparison of the Carbapenems Against E. coli and Klebsiella spp. Containing Extended spectrum β-lactamasesKathryn J. Eagye, Joseph L. Kuti, David P. NicolauCarbapenems are the treatment of choice for extended-spectrum β-lactamases (ESBLs). Ertapenem is a new member of the carbapenem class, and is often grouped with imipenem and meropenem as a recommended treatment for ESBLs. However, new in vitro data question ertapenem’s inclusion as a first line treatment for these bacteria, suggesting that ertapenem has a lower likelihood of obtaining appropriate pharmacodynamic … …American Journal of Infectious Diseases, Vol. 1, Issue 3 · 30 Sep 2005 · 6,886 accessesView PDF Cite

Research ArticleOpen accessIn the abstractExogenous Re-infection by Multiple Exposures to Mycobacterium tuberculosis Contributes to Subsequent Development of Active TuberculosisDiane J. Ordway, Miguel Viveiros, Fernando A. Ventura et al.The majority of tuberculosis (TB) exists in the world’s poorest countries, where costly biosafety level three facilities for containment of infectious TB patients and diagnostic facilities are not affordable. Health care workers (HCWs), in countries with high burdens of tuberculosis (TB) are at risk of nosocomially acquired TB, as there are increased numbers of cases of TB on open hospital … …American Journal of Immunology, Vol. 1, Issue 1 · 31 Mar 2005 · 6,967 accessesView PDF Cite